CNC - Earnings announcements

ST. LOUIS, April 10, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, shared today that it will release its 2026 first quarter financial results at approximately 6:00 a.m. ET on Tuesday, April 28, 2026, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 (toll free) in the U.S. and Canada; +1-412-902-6506 (toll) from abroad, including the following Elite Entry Number: 0526

-- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- Consolidated HBR of 94.3% in the fourth quarter of 2025, which includes a Commercial HBR of 95.4% that was 100 basis points higher than expectations driven by net out of period items.Medicaid HBR of 93.0% in the fourth quarter of 2025, reflecting continued progress and representing 40 basis points of sequential improvement compared to the third quarter.Fundamental fourth quarter 2025 trend was consistent with expectations in Medicaid and Medicare Advantage, and slightly favorable in Marketplace and Medicare PD

ST. LOUIS, Jan. 13, 2026 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Friday, February 6, 2026, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2815529 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under

-- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 -- Adjusted diluted EPS of $0.50 in the third quarter of 2025, including a $0.10 benefit of a low adjusted effective tax rate in the quarter as compared to the expected full year adjusted effective tax rate of 20-21%.$6.7 billion non-cash goodwill impairment, resulting in a GAAP loss and corresponding reduction of retained earnings in the third quarter of 2025. After the reduction to retained earnings, the debt-to-capital ratio was 45.5% at September 30, 2025.Medicaid HBR of 93.4% in the third quarter, including an approximate 40 basis point benefit from a retroactive revenue adjustment attributed to the

ST. LOUIS, Sept. 29, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 third quarter financial results at approximately 6:00 a.m. ET on Wednesday, October 29, 2025, and host a conference call at 9:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 0266211 to ex

-- Diluted Loss Per Share of $(0.51); Adjusted Diluted Loss Per Share of $(0.16) -- ST. LOUIS, July 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2025. In summary, the 2025 second quarter results were as follows: Total revenues (in millions) $             48,742 Premium and service revenues (in millions) $             42,467 Health benefits ratio 93.0 % SG&A expense ratio 7.1 % Adjusted SG&A expense ratio (1) 7.1 % GAAP diluted loss per share $                (0.51) Adjusted diluted loss per share (1) $                (0.16) Total cash flow provided by operations (in millions) $              

CALL MOVED TO 8AM ET ST. LOUIS, July 22, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 25, 2025, and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 7878291 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, 

-- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total

ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors

-- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December

ST. LOUIS, Jan. 15, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 fourth quarter and year-end financial results at approximately 6:00 a.m. ET on Tuesday, February 4, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1342288 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, unde

-- 2025 adjusted diluted EPS of greater than $7.25 -- -- Reaffirms 2024 adjusted diluted EPS guidance of greater than $6.80 -- ST. LOUIS, Dec. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company"), a leading healthcare enterprise committed to helping people live healthier lives, today will host its investor day to outline its 2025 financial guidance. "Centene is a mission driven organization, dedicated to delivering high quality outcomes for more than 28 million members, many of whom are among the nation's most medically complex and historically underserved populations. Over the last three years we improved our core operations and invested in the experience of our customer

-- Diluted EPS of $1.36; Adjusted Diluted EPS of $1.62 -- -- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $1.62 in the third quarter of 2024.Premium and service revenues of $36.9 billion in the third quarter of 2024.Membership increases of 22% in Marketplace and 49% in Medicare Prescription Drug Plans, compared to the third quarter of 2023.Continued execution on capital deployment with $1.2 billion of share repurchases during the third quarter of 2024 and an additional $380 million in October, bringing full-year repurchases to $2.4 billion through October 2024.ST. LOUIS, Oct. 25, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the

ST. LOUIS, Oct. 8, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 third quarter financial results at approximately 6:00 a.m. ET on Friday, October 25, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 1267976 to expedite

-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.42 ---- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $2.42, up 15% from $2.10 in the second quarter of 2023.Premium and service revenues of $36.0 billion in the second quarter of 2024.Membership increase of 34% in Marketplace, compared to the second quarter of 2023.ST. LOUIS, July 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the second quarter ended June 30, 2024. In summary, the 2024 second quarter results were as follows: Total revenues (in millions) $             39,836 Premium and service revenues (in millions) $ 

ST. LOUIS, July 2, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 second quarter financial results at approximately 6:00 a.m. ET on Friday, July 26, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 4980577 to expedite c

-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to greater than $6.80.Premium and service revenues of $36.3 billion in the first quarter of 2024. Increases 2024 full year premium and service revenue guidance by $1.0 billion.Membership increase of 41% in Marketplace, compared to the first quarter of 2023.ST. LOUIS, April 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the first quarter ended March 31, 2024. In summary, the 2024 fir

ST. LOUIS, March 7, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2024 first quarter financial results at approximately 6 a.m. ET on Friday, April 26, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9229812, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors sec

-- 2023 Full Year Diluted EPS of $4.95; Adjusted Diluted EPS of $6.68 -- 2023 adjusted diluted EPS of $6.68, up over 15% from $5.78 in 2022.2023 health benefits ratio of 87.7%, consistent with 2022.Executed on capital deployment with $1.6 billion of share repurchases in 2023.Successful portfolio review execution, completing the final two international divestitures in the past two months: Circle Health and Operose Health. Increased 2024 premium and service revenues guidance by $2.5 billion.ST. LOUIS, Feb. 6, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December 31, 2023. In summary, the 2023 fou

ST. LOUIS, Jan. 23, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) issued a reminder today that it will release its 2023 fourth quarter and full year financial results at approximately 6 a.m. ET on Tuesday, February 6, 2024, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 3061147, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast replay will be available for on-demand l

2024 adjusted diluted EPS of greater than $6.70.Board authorizes $4.0 billion increase to stock repurchase program.Reaffirms 2023 adjusted diluted EPS guidance of at least $6.60.ST. LOUIS, Dec. 12, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") today will host its investor day to outline its 2024 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value. "We continue to execute against our strategic plan, positioning Centene to deliver strong, long-term earnings growth and create meaningful shareholder value. Looking to the year ahead, we see the opportunity to provide access to high-quality health car

ST. LOUIS, Oct. 3, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise that is committed to helping people live healthier lives, announced that it will release its 2023 third quarter financial results at approximately 6 a.m. EDT on Tuesday, October 24, 2023, and will host a conference call afterwards at approximately 8:30 a.m. EDT to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 3130388, to expedite caller registration; or via a live, audio webcast on the Company's website at www.

-- Diluted EPS of $1.92; Adjusted Diluted EPS of $2.10 -- -- Increases 2023 Full Year Guidance -- Adjusted diluted EPS of $2.10, up over 18% from $1.77 in the second quarter of 2022.Premium and service revenues of $34.8 billion in the second quarter of 2023.Medicaid redeterminations progressing as expected.Increases 2023 full year adjusted diluted EPS guidance by $0.05 to at least $6.45; reiterates 2024 adjusted diluted EPS floor of greater than $6.60.ST. LOUIS, July 28, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the second quarter ended June 30, 2023. In summary, the 2023 second quarter results were as follows: Total revenue

-- Diluted EPS of $2.04; Adjusted Diluted EPS of $2.11 -- -- Increases 2023 Full Year Guidance and Updates 2024 Target -- Increased 2023 full year Adjusted EPS guidance to at least $6.40 driven by strong performance in its market leading Medicaid and Marketplace businesses.Premium and service revenues of $35.0 billion in the first quarter of 2023.Health benefits ratio of 87.0% in the first quarter of 2023, driven by continued disciplined Marketplace pricing and favorable Medicare performance.Updates the 2024 Adjusted EPS target to greater than $6.60, reflecting an updated view of Medicaid redeterminations, Medicare bid strategy, and business investments, to be further discussed on the earnin

ST. LOUIS , March 31, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today announced that it will release its 2023 first quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, April 25, 2023, and will host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 8655989, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast replay wil

-- 2022 Full Year Diluted EPS of $2.07; Adjusted Diluted EPS of $5.78 -- 2022 adjusted diluted EPS growth of 12%.2022 total revenues of $144.5 billion, up 15%.2022 health benefits ratio of 87.7%.Continued progress on portfolio review, completing five divestitures in the past three months: Magellan Rx, Magellan Specialty Health, Ribera Salud, Centurion, and HealthSmart.Executed on capital deployment with $1.4 billion of share repurchases in the fourth quarter, bringing full year repurchases to $3.0 billion, largely funded through divestiture proceeds.Increased 2023 premium and service revenues guidance by $2.0 billion.ST. LOUIS, Feb. 7, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) anno

ST. LOUIS, Jan. 13, 2023 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today issued a reminder that it will release its 2022 fourth quarter and full year financial results at approximately 6 a.m. (Eastern Time) on Tuesday, February 7, 2023, and will host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 6826970, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section

2023 Adjusted Diluted EPS of $6.25 to $6.40 Announces Long-Term Adjusted Diluted EPS CAGR Target of 12% - 15%Board Authorizes $2 Billion Increase to Stock Repurchase ProgramST. LOUIS, Dec. 16, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today will host its investor day to outline its 2023 financial guidance as well as provide updates on its long-term strategic plan, designed to deliver long-term shareholder value. "We are pleased with the progress we have made on our Value Creation Plan in 2022. The momentum we have built will propel us into 2023 and beyond," said Sarah M. London, Chief Executive Officer of Centene. "We look forward to sharing more about Centene's long-term strategy

-- Diluted EPS of $1.27; Adjusted Diluted EPS of $1.30 -- Total revenues up 11% from the third quarter of 2021 driven by organic Medicaid and Medicare growth.Health benefits ratio (HBR) of 88.3%, driven by strong Medicare results and inline performance from Medicaid and Commercial.Value Creation Plan gaining momentum: Pulling margin levers including Medicare and Marketplace bid discipline, real estate and cost rationalization;Executing on capital deployment initiatives including $1.7 billion and $300 million year-to-date share repurchase and debt repurchase, respectively; andAward of the new pharmacy benefits management (PBM) contract to Express Scripts, Inc., commencing in 2024.4th guidance

ST. LOUIS, Oct. 5, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today issued a reminder that it will release its 2022 third quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, October 25, 2022, and will host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 6216529, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast rep

-- Diluted Loss Per Share of $(0.29), including real estate charge; Adjusted Diluted EPS of $1.77 -- Total revenues up 16% from the second quarter of 2021 driven by organic Medicaid and Medicare growth.Health benefits ratio (HBR) of 86.7%, largely driven by Marketplace.Execution of Value Creation Plan through real estate optimization, divestitures, and share repurchases.Increased 2022 full-year adjusted diluted EPS guidance by another $0.05 (to a range of $5.60 to $5.75), reflecting a $0.20 cumulative increase above our April guidance.ST. LOUIS, July 26, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today its financial results for the second quarter ended June 30, 2022. In su

ST. LOUIS, June 30, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today issued a reminder that it will release its 2022 second quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, July 26, 2022, and will host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 2306827, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast repl

TORONTO, May 16, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG, TSXV:SLHG) ("Skylight Health" or the "Company"), a multi-state primary care management group in the United States, today announced its financial results for the first quarter ended March 31, 2022. Strong revenue growth of 255% Year over Year through the continued acquisition of primary care practices.Accelerates its 3-5 year journey to Medicare Advantage ("MA") full risk into 2022 with the acquisition of NeighborMD ("NMD") and the joint venture ("JV") with Collaborative Health Systems ("CHS").Over $70 million revenue run rate on a proforma basis with the acquisition of NMD and before any revenue synergies

-- Diluted EPS of $1.44; Adjusted Diluted EPS of $1.83 -- -- Raises Total Revenue and Adjusted EPS Guidance -- ST. LOUIS, April 26, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today its financial results for the first quarter ended March 31, 2022, reporting diluted earnings per share (EPS) of $1.44 and adjusted diluted EPS of $1.83. In summary, the 2022 first quarter results were as follows: Total revenues (in millions) $             37,185 Premium and service revenues (in millions) $             34,232 Health benefits ratio 87.3 % SG&A expense ratio 8.0 % Adjusted SG&A expense ratio (1) 7.7 % GAAP diluted EPS $                 1.44 Adjusted diluted EPS (1) $               

– Live Audio Webcast of Annual Meeting Available – ST. LOUIS, April 1, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today announced that following the release of its 2022 first quarter financial results on Tuesday, April 26, 2022, the Company will hold its 2022 Annual Meeting of Stockholders at 11:00 a.m. (Eastern Time)/10:00 a.m. (Central Time) in the auditorium at Centene's headquarters, 7700 Forsyth Boulevard, St. Louis, Missouri.  At the meeting, Centene is expected to make remarks regarding the Company's performance and future prospects. A live audio webcast of the meeting can be accessed via the Company's website at www.centene.com under the Investors section. About Centene Corp

ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today issued a reminder that it will release its 2022 first quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, April 26, 2022, and will host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 7792929, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors section.  A webcast rep

ST. LOUIS, Feb. 8, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today its financial results for the fourth quarter and year ended December 31, 2021, reporting diluted earnings per share (EPS) of $1.01 and $2.28, respectively, and adjusted diluted EPS of $1.01 and $5.15, respectively. In summary, the 2021 fourth quarter and full year results were as follows: 2021 Results Q4 Full Year Total revenues (in millions) $             32,568 $           125,982 Premium and service revenues (in millions) $             30,493 $           117,983 Health benefits ratio 87.9% 87.8% SG&A expense ratio 9.3% 8.6% Adjusted SG&A expense ratio (1) 9.2% 8.4% GAAP diluted EPS $                  1.

ST. LOUIS, Jan. 10, 2022 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today issued a reminder that it will release its 2021 fourth quarter and full-year financial results at approximately 6 a.m. Eastern Standard Time (EST) on Tuesday, February 8th, 2022, and host a conference call afterwards at approximately 8:30 a.m. (EST) to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9243013, to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors secti

ST. LOUIS, Dec. 10, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today will host its investor day virtually and outline its 2022 financial guidance as well as provide details of its Value Creation Plan, designed to deliver enhanced earnings growth and create long-term shareholder value. "Centene has delivered strong results during 2021 as we extended our position as a leading healthcare enterprise committed to transforming the health of the community, one person at a time. Our Medicaid, Medicare, and Marketplace products are well positioned amid a dynamic and evolving healthcare landscape. The strong leadership from our executive teams and the dedication of our employees to support ou

ST. LOUIS, Oct. 26, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today its financial results for the third quarter ended September 30, 2021, reporting diluted earnings per share (EPS) of $0.99 and adjusted diluted EPS of $1.26. In summary, the 2021 third quarter results were as follows: Total revenues (in millions) $ 32,406 Health benefits ratio 88.1 % SG&A expense ratio 8.8 % Adjusted SG&A expense ratio (1) 8.6 % GAAP diluted EPS $ 0.99 Adjusted diluted EPS (1) $ 1.26 Total cash flow provided by operations (in millions) $ 1,802 (1) A full reconciliation of the adjusted SG&A expense ratio and adjusted diluted EPS is shown on page 7 of this release.   "We are pleased with our

ST. LOUIS, Sept. 14, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) today issued a reminder that it will release its 2021 third quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, October 26, 2021, and host a conference call afterwards at approximately 8:30 a.m. (Eastern Time) to review the results. Michael F. Neidorff, Chairman and Chief Executive Officer, and Drew Asher, Executive Vice President and Chief Financial Officer, of Centene Corporation will host the call. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entr

ST. LOUIS, July 27, 2021 /PRNewswire/ -- Centene Corporation (NYSE:CNC) announced today its financial results for the second quarter ended June 30, 2021, reporting diluted loss per share of $(0.92) and adjusted diluted earnings per share (EPS) of $1.25. In summary, the 2021 second quarter results were as follows: Total revenues (in millions) $ 31,025 Health benefits ratio 88.3 % SG&A expense ratio 7.9 % Adjusted SG&A expense ratio (1) 7.7 % GAAP diluted loss per share $ (0.92) Adjusted diluted EPS (1) $ 1.25 Total cash flow provided by operations (in millions) $ 1,685 (1) A full reconciliation of the adjusted SG&A expense ratio and adjusted diluted EPS is shown on page 6 of this release.   "